Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center
- 1 February 2003
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (2) , 485-489
- https://doi.org/10.1016/s0003-4975(02)04367-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-upEuropean Heart Journal, 2001
- The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured?European Heart Journal, 2001
- Elective stenting of unprotected left main coronary artery stenosisJournal of the American College of Cardiology, 2001
- The rapamycin-sensitive signal transduction pathway as a target for cancer therapyOncogene, 2000
- CORONARY DISEASE: Intervention in coronary artery diseaseHeart, 2000
- ACC expert consensus document on coronary artery stentsJournal of the American College of Cardiology, 1998
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.Journal of Clinical Investigation, 1997
- Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel DiseaseNew England Journal of Medicine, 1996
- Three-year follow-up of the argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI)Journal of the American College of Cardiology, 1996